Jiang, Z., Luo, T., Liu, H., Wang, X., Wang, T., Li, H., Yang, J., Li, Y., Yan, M., Yin, Y., Yao, J., Li, J., Pan, Y., Zhu, X., Xin, W., Zhang, D. (2026). HRS-8080, an oral selective estrogen receptor degrader (SERD), in ER+/HER2− advanced breast cancer (aBC) with
ESR1
mutations (
ESR1
m): Results from a first-in-human phase 1 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.1069